Hydrocortisone Sodium Succinate Injection — FDA Drug Shortage

No longer listed by FDA — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Hydrocortisone Sodium Succinate Injection (injection) from Hospira, Inc., A Pfizer Company with status No longer listed by FDA. The shortage was first posted on Mar 24, 2023.

Shortage details

Status
No longer listed by FDA
Company
Hospira, Inc., A Pfizer Company
Package NDC
0009-0825-01
Dosage Form
Injection
Presentation
Solu-cortef, Injection, 100 mg/vial (NDC 0009-0825-01)
Initial Posting
Mar 24, 2023

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.